| Secondary |
| Product Used For Unknown Indication |
37.4% |
| Drug Use For Unknown Indication |
16.4% |
| Depression |
9.6% |
| Hypertension |
7.3% |
| Embolism |
4.6% |
| Bipolar I Disorder |
3.7% |
| Embolism Arterial |
3.7% |
| Drug Toxicity |
2.7% |
| Pain |
2.7% |
| Poisoning Deliberate |
1.8% |
| Benign Prostatic Hyperplasia |
1.4% |
| Gastric Ulcer |
1.4% |
| Pulmonary Embolism |
1.4% |
| Acne |
0.9% |
| Dyslipidaemia |
0.9% |
| Dysthymic Disorder |
0.9% |
| Lung Adenocarcinoma |
0.9% |
| Mental Disorder |
0.9% |
| Panic Disorder |
0.9% |
| Agitation |
0.5% |
|
| Suicide Attempt |
10.6% |
| Orthostatic Intolerance |
8.5% |
| Pneumomediastinum |
8.5% |
| Syncope |
8.5% |
| Rhabdomyolysis |
6.4% |
| Cytolytic Hepatitis |
4.3% |
| Hyponatraemia |
4.3% |
| Jaundice |
4.3% |
| Mental Disorder |
4.3% |
| Neuroleptic Malignant Syndrome |
4.3% |
| Psychiatric Decompensation |
4.3% |
| Pupils Unequal |
4.3% |
| Shock Haemorrhagic |
4.3% |
| Somnolence |
4.3% |
| Subileus |
4.3% |
| Tachycardia |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Condition Aggravated |
2.1% |
| Dementia |
2.1% |
| Diabetes Mellitus |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.5% |
| Drug Use For Unknown Indication |
14.1% |
| Depression |
10.6% |
| Hepatitis C |
6.7% |
| Anxiety |
4.7% |
| Insomnia |
4.5% |
| Anaesthesia |
2.7% |
| Blood Corticotrophin Decreased |
2.2% |
| Hypothyroidism |
2.0% |
| Agitation |
1.8% |
| Hepatic Cirrhosis |
1.8% |
| Infection |
1.8% |
| Mental Disorder |
1.8% |
| Bipolar Disorder |
1.6% |
| Epilepsy |
1.6% |
| Major Depression |
1.6% |
| Pain |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Growth Hormone Deficiency |
1.4% |
| Multiple Sclerosis |
1.4% |
|
| Thrombocytopenia |
17.3% |
| Pulmonary Embolism |
12.3% |
| Condition Aggravated |
8.6% |
| Suicide Attempt |
7.4% |
| Borderline Ovarian Tumour |
4.9% |
| Disorientation |
4.9% |
| Weight Increased |
4.9% |
| Coronary Artery Stenosis |
3.7% |
| Extrapyramidal Disorder |
3.7% |
| Leukopenia |
3.7% |
| Poisoning |
3.7% |
| Shock |
3.7% |
| Somnolence |
3.7% |
| Cytolytic Hepatitis |
2.5% |
| Epilepsy |
2.5% |
| General Physical Health Deterioration |
2.5% |
| Insomnia |
2.5% |
| Loose Tooth |
2.5% |
| Oesophageal Ulcer |
2.5% |
| Pleurisy |
2.5% |
|
| Interacting |
| Pain |
66.7% |
| Product Used For Unknown Indication |
33.3% |
|
| Drug Interaction |
33.3% |
| Lip Oedema |
33.3% |
| Transaminases Increased |
33.3% |
|
